274 results on '"Atanasov, Petar"'
Search Results
2. Unlocking the Value: Quantifying the Return on Investment of Hospital Artificial Intelligence
3. Targeted Literature Review of the Burden of Respiratory Syncytial Infection among High-Risk and Elderly Patients in Asia Pacific Region
4. Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
5. Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients
6. Surface-Enhanced Raman Spectroscopy of Ammonium Nitrate Using Al Structures, Fabricated by Laser Processing of AlN Ceramic
7. Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis.
8. Application of Aluminium Nanostructures for 355 nm Surface-enhanced Raman Spectroscopy of Coconut Milk
9. MULTIVARIATE ANALYSIS OF DISCRIMINATION AND SOCIAL INDICATORS IN THE WESTERN BALKANS COUNTRIES.
10. Fabrication of Nanostructures Consisting of Composite Nanoparticles by Open-Air PLD.
11. Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis
12. Prevention of cardiovascular diseases
13. Laparoscopic IPOMPLUS repair-current outcomes and complications
14. Monitoring the change in the quality of life of patients with post-COVID syndrome by influence on their functional status
15. Sex-specific Impact of 17β-estradiol and Testosterone Levels on Inflammation and Injury in Acute Myocardial Infarction
16. Picosecond Pulsed Laser Deposition of Metals and Metal Oxides
17. Cytotoxic activity of Galantamine hydrobromide against HeLa cell line
18. Figure 2 from: Obreshkova D, Atanasov P, Chaneva M, Ivanova S, Balkanski S, Peikova L (2023) Cytotoxic activity of Galantamine hydrobromide against HeLa cell line. Pharmacia 70(3): 619-623. https://doi.org/10.3897/pharmacia.70.e109841
19. Figure 1 from: Obreshkova D, Atanasov P, Chaneva M, Ivanova S, Balkanski S, Peikova L (2023) Cytotoxic activity of Galantamine hydrobromide against HeLa cell line. Pharmacia 70(3): 619-623. https://doi.org/10.3897/pharmacia.70.e109841
20. Figure 4 from: Obreshkova D, Atanasov P, Chaneva M, Ivanova S, Balkanski S, Peikova L (2023) Cytotoxic activity of Galantamine hydrobromide against HeLa cell line. Pharmacia 70(3): 619-623. https://doi.org/10.3897/pharmacia.70.e109841
21. Figure 3 from: Obreshkova D, Atanasov P, Chaneva M, Ivanova S, Balkanski S, Peikova L (2023) Cytotoxic activity of Galantamine hydrobromide against HeLa cell line. Pharmacia 70(3): 619-623. https://doi.org/10.3897/pharmacia.70.e109841
22. Nanoporous TiO2 electrode grown by laser ablation of titanium in air at atmospheric pressure and room temperature
23. Antitumor and antioxidant activity of some metal complex compounds
24. Laser processing of biopolymers for development of medical and high-tech devices
25. List of Contributors
26. Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data
27. Comparative analysis of comorbidity, surgical complications, pharmacotherapeutic needs, and rehabilitation requirements in transabdominal preperitoneal hernia repair versus conventional operative treatment-current results and benefits.
28. Anxiety in the emergency medical practice - its psychiatric and somatic origin, comorbidities, behavior and treatment.
29. Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review.
30. Aluminum nanostructures for 355 nm surface‐enhanced Raman spectroscopy of fluorescing chemicals.
31. Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement.
32. Risk Factors for Pulmonary Arterial Hypertension in Patients With Systemic Lupus Erythematosus: A Systematic Review and Expert Consensus.
33. Figure 2 from: Pantileeva D, Rangelova D, Atanasov P, Mircheva S, Ivanov I, Chaneva M, Obreshkova D, Ivanova S, Milanov S, Kazalakova K, Dimitrov V, Petkova V, Baltov A, Petrov S (2023) Logistical challenges with an emphasis on organizing specialized triage in the conditions of a newly emerging, epidemiologically significant infectious pathogen for humans – SARS-CoV2. Pharmacia 70(1): 129-137. https://doi.org/10.3897/pharmacia.70.e101353
34. Figure 1 from: Pantileeva D, Rangelova D, Atanasov P, Mircheva S, Ivanov I, Chaneva M, Obreshkova D, Ivanova S, Milanov S, Kazalakova K, Dimitrov V, Petkova V, Baltov A, Petrov S (2023) Logistical challenges with an emphasis on organizing specialized triage in the conditions of a newly emerging, epidemiologically significant infectious pathogen for humans – SARS-CoV2. Pharmacia 70(1): 129-137. https://doi.org/10.3897/pharmacia.70.e101353
35. Logistical challenges with an emphasis on organizing specialized triage in the conditions of a newly emerging, epidemiologically significant infectious pathogen for humans – SARS-CoV2
36. Targeted literature review of the burden of extraintestinal pathogenic Escherichia Coli among elderly patients in Asia Pacific regions
37. Laparoscopic IPOMPLUS repair-current outcomes and complications.
38. Operative management of acute cholecystitis in pregnancy: Case report.
39. Monitoring the change in the quality of life of patients with post-COVID syndrome by influence on their functional status.
40. Immune response – genesis, duration, and strength in patients with moderate and severe coronavirus infection of different age groups.
41. Use of Lesion Response Rate in Actinic Keratosis Trials
42. Macedonian Reform Perspectives
43. Figure 2 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095
44. Supplementary material 1 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095
45. Figure 4 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095
46. Figure 5 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095
47. Figure 3 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095
48. Figure 6 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095
49. Figure 1 from: Atanasov P, Moneva-Sakelarieva M, Kobakova Y, Obreshkova D, Ivanov I, Chaneva M, Popova M, Petkova V, Ivanova S (2022) Tobacco smokers as target group for complicated coronavirus infection. Pharmacia 69(3): 791-800. https://doi.org/10.3897/pharmacia.69.e91095
50. Tobacco smokers as target group for complicated coronavirus infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.